FDA 483 - Geneoscopy, Inc. - May 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Geneoscopy, Inc., a medical device manufacturer in Saint Louis, MO, identified two significant observations related to quality system procedures. The firm failed to establish procedures for finished device acceptance and adequately establish procedures for device history records, specifically concerning their Stool Sample Collection kits. These issues indicate deficiencies in ensuring proper control and documentation of medical device manufacturing and release.
ID · eef640cb-6371-41f2-9e21-44671ea01958